Logo image of ALVGO.PA

VOGO SACA (ALVGO.PA) Stock Fundamental Analysis

EPA:ALVGO - Euronext Paris - Matif - FR0011532225 - Common Stock - Currency: EUR

2.68  +0.03 (+1.13%)

Fundamental Rating

2

Overall ALVGO gets a fundamental rating of 2 out of 10. We evaluated ALVGO against 102 industry peers in the Software industry. ALVGO has a bad profitability rating. Also its financial health evaluation is rather negative. ALVGO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALVGO has reported negative net income.
In the past year ALVGO has reported a negative cash flow from operations.
ALVGO had negative earnings in each of the past 5 years.
In the past 5 years ALVGO always reported negative operating cash flow.
ALVGO.PA Yearly Net Income VS EBIT VS OCF VS FCFALVGO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.50%, ALVGO is doing worse than 67.65% of the companies in the same industry.
With a Return On Equity value of -14.65%, ALVGO is not doing good in the industry: 67.65% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.5%
ROE -14.65%
ROIC N/A
ROA(3y)-8.46%
ROA(5y)-9.78%
ROE(3y)-20.42%
ROE(5y)-23.22%
ROIC(3y)N/A
ROIC(5y)N/A
ALVGO.PA Yearly ROA, ROE, ROICALVGO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

ALVGO has a worse Gross Margin (57.07%) than 61.76% of its industry peers.
In the last couple of years the Gross Margin of ALVGO has grown nicely.
The Profit Margin and Operating Margin are not available for ALVGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.4%
GM growth 5YN/A
ALVGO.PA Yearly Profit, Operating, Gross MarginsALVGO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

2

2. Health

2.1 Basic Checks

ALVGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALVGO has more shares outstanding
The number of shares outstanding for ALVGO has been increased compared to 5 years ago.
The debt/assets ratio for ALVGO is higher compared to a year ago.
ALVGO.PA Yearly Shares OutstandingALVGO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALVGO.PA Yearly Total Debt VS Total AssetsALVGO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of 0.96, we must say that ALVGO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.96, ALVGO is doing worse than 71.57% of the companies in the same industry.
ALVGO has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
ALVGO has a Debt to Equity ratio of 0.43. This is comparable to the rest of the industry: ALVGO outperforms 40.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACCN/A
WACC8.13%
ALVGO.PA Yearly LT Debt VS Equity VS FCFALVGO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

ALVGO has a Current Ratio of 1.85. This is a normal value and indicates that ALVGO is financially healthy and should not expect problems in meeting its short term obligations.
ALVGO has a better Current ratio (1.85) than 70.59% of its industry peers.
A Quick Ratio of 1.02 indicates that ALVGO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.02, ALVGO is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.02
ALVGO.PA Yearly Current Assets VS Current LiabilitesALVGO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.08% over the past year.
Looking at the last year, ALVGO shows a quite strong growth in Revenue. The Revenue has grown by 10.25% in the last year.
ALVGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.80% yearly.
EPS 1Y (TTM)39.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.64%
Revenue 1Y (TTM)10.25%
Revenue growth 3Y7.48%
Revenue growth 5Y42.8%
Sales Q2Q%-3.4%

3.2 Future

Based on estimates for the next years, ALVGO will show a very strong growth in Earnings Per Share. The EPS will grow by 43.93% on average per year.
The Revenue is expected to grow by 18.01% on average over the next years. This is quite good.
EPS Next Y42.5%
EPS Next 2Y33.23%
EPS Next 3Y43.93%
EPS Next 5YN/A
Revenue Next Year36.36%
Revenue Next 2Y24.32%
Revenue Next 3Y18.01%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALVGO.PA Yearly Revenue VS EstimatesALVGO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
ALVGO.PA Yearly EPS VS EstimatesALVGO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

ALVGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALVGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALVGO.PA Price Earnings VS Forward Price EarningsALVGO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALVGO.PA Per share dataALVGO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as ALVGO's earnings are expected to grow with 43.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.23%
EPS Next 3Y43.93%

0

5. Dividend

5.1 Amount

No dividends for ALVGO!.
Industry RankSector Rank
Dividend Yield N/A

VOGO SACA

EPA:ALVGO (6/18/2025, 7:00:00 PM)

2.68

+0.03 (+1.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)07-23 2025-07-23
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners28.99%
Ins Owner ChangeN/A
Market Cap16.43M
Analysts84
Price Target2.91 (8.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-33.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1250%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.55
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 8.44
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.73
BVpS2.01
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.5%
ROE -14.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.07%
FCFM N/A
ROA(3y)-8.46%
ROA(5y)-9.78%
ROE(3y)-20.42%
ROE(5y)-23.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.4%
GM growth 5YN/A
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 154.34%
Cap/Sales 20.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.02
Altman-Z 0.96
F-Score4
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)200.88%
Cap/Depr(5y)198.36%
Cap/Sales(3y)20.88%
Cap/Sales(5y)19.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.64%
EPS Next Y42.5%
EPS Next 2Y33.23%
EPS Next 3Y43.93%
EPS Next 5YN/A
Revenue 1Y (TTM)10.25%
Revenue growth 3Y7.48%
Revenue growth 5Y42.8%
Sales Q2Q%-3.4%
Revenue Next Year36.36%
Revenue Next 2Y24.32%
Revenue Next 3Y18.01%
Revenue Next 5YN/A
EBIT growth 1Y0.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year133.33%
EBIT Next 3Y42.96%
EBIT Next 5YN/A
FCF growth 1Y29.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.51%
OCF growth 3YN/A
OCF growth 5YN/A